emzadirib
Term · Oncology and biomedicine · MLC-T-ONC-013329
An orally bioavailable inhibitor of the DNA damage repair protein RAD51, with potential antineoplastic and sensitizing activities. Upon oral administration, emzadirib targets, binds to and inhibits the activity of RAD51. This prevents RAD51-mediated DNA damage repair in susceptible tumor cells and induces tumor cell apoptosis. RAD51, the central protein involved in homologous repair (HR) of DNA double-strand breaks (DSBs), is overexpressed in many tumor cell types.
| Identifier | MLC-T-ONC-013329 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | RAD51 inhibitor CYT-0851 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013329",
"term": "emzadirib",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable inhibitor of the DNA damage repair protein RAD51, with potential antineoplastic and sensitizing activities. Upon oral administration, emzadirib targets, binds to and inhibits the activity of RAD51. This prevents RAD51-mediated DNA damage repair in susceptible tumor cells and induces tumor cell apoptosis. RAD51, the central protein involved in homologous repair (HR) of DNA double-strand breaks (DSBs), is overexpressed in many tumor cell types.",
"synonyms": [
"RAD51 inhibitor CYT-0851"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/emzadirib/"
}
Record 6,604 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.